Neu REFIX β-glucan riduce la fibrosi muscolare in topi MDX con distrofia muscolare di Duchenne, in uno studio congiunto con il Dr. Yoshitsugu Aoki, NCNP, Tokyo, Giappone.

La pubblicazione su Scientific Reports documenta anche il controllo dell'infiammazione.

An illustrative summary of the research outcome with Neu REFIX Beta glucan presents, several “Firsts” to its credit; (1) Oral consumption of a food supplement alone, without any other drugs, reducing skeletal muscle fibrosis in MDX mice, (2) In clinical studies, increase in plasma dystrophin which is considered of relevance to correction of vascular smooth muscle pathology, (3) Clinically evident beneficial reconstitution of gut microbiome in patients with DMD in a 45- days clinical study, (4) Reduction of myocardial fibrosis with neu REFIX alone in MDX mice, (5) Slowing down the progress of DMD pathology evident by 6MWT, NSAA and MRC in a six-month clinical study when Neu REFIX was consumed along with standard of care medication; Neu REFIX 1,3-1,6 Beta glucan is a food supplement without any therapeutic claims; Not a drug or remedy to any illness. Research findings not to be construed as medical advice. Neu REFIX doesn’t contain any of the commonly notified 28 allergens.

  • An illustrative summary of the research outcome with Neu REFIX Beta glucan presents, several “Firsts” to its credit; (1) Oral consumption of a food supplement alone, without any other drugs, reducing skeletal muscle fibrosis in MDX mice, (2) In clinical studies, increase in plasma dystrophin which is considered of relevance to correction of vascular smooth muscle pathology, (3) Clinically evident beneficial reconstitution of gut microbiome in patients with DMD in a 45- days clinical study, (4) Reduction of myocardial fibrosis with neu REFIX alone in MDX mice, (5) Slowing down the progress of DMD pathology evident by 6MWT, NSAA and MRC in a six-month clinical study when Neu REFIX was consumed along with standard of care medication; Neu REFIX 1,3-1,6 Beta glucan is a food supplement without any therapeutic claims; Not a drug or remedy to any illness. Research findings not to be construed as medical advice. Neu REFIX doesn’t contain any of the commonly notified 28 allergens.

TOKYO--()--La fibrosi del muscolo scheletrico che porta alla disfunzione locomotoria nella distrofia muscolare di Duchenne (DMD) potrebbe essere ridotta significativamente con l'assunzione orale di Neu-REFIX beta glucani 1,3-1,6 in monoterapia per 45 giorni senza aggiunta di altri farmaci, in modelli murini (MDX) di DMD. Questa ricerca è stata condotta congiuntamente dal team del Dr. Yoshitsugu Aoki, Responsabile del Dipartimento di Terapia molecolare, National Center for Neurology and Psychiatry (NCNP), Tokyo, Giappone, un pioniere nello sviluppo di soluzioni per la DMD come la terapia skipping dell'esone.

Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono rinviare al testo in lingua originale, che è l'unico giuridicamente valido.

Contacts

Samuel JK Abraham
info@gncorporation.com

Contacts

Samuel JK Abraham
info@gncorporation.com